ARCHIVES

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

DCBD Board Approves Concepts For 43.5 Million In New Grants, $1.9 Million In Contract Supported Projects

November 13, 1981

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992

Large Bowel Study Expansion Hampered By Lack Of Coordination, NCI Admits

May 17, 1974

Mammography Reports Complete; Breast Project to Continue

March 25, 1977